Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mythili Merchant"'
Autor:
Mythili Merchant, Margarita Raygada, Ying Pang, Martha Quezado, Mark Raffeld, Liqiang Xi, Jung Kim, Manoj Tyagi, Zied Abdullaev, Olga Kim, Zach Sergi, Tina Pillai, Byram Ozer, Kareem Zaghloul, John D. Heiss, Terri S. Armstrong, Mark R. Gilbert, Kenneth Aldape, Jing Wu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Most tumors, including brain tumors, are sporadic. However, a small subset of CNS tumors are associated with hereditary cancer conditions like Lynch Syndrome (LS). Here, we present a case of an oligodendroglioma, IDH-mutant and 1p/19q-codeleted, and
Externí odkaz:
https://doaj.org/article/04af4ed4ed57478996d43c9cd4a65e33
Autor:
Guangyang Yu, Ying Pang, Mythili Merchant, Chimene Kesserwan, Vineela Gangalapudi, Abdalla Abdelmaksoud, Alice Ranjan, Olga Kim, Jun S. Wei, Hsien-Chao Chou, Xinyu Wen, Sivasish Sindiri, Young K. Song, Liqiang Xi, Rosandra N. Kaplan, Terri S. Armstrong, Mark R. Gilbert, Kenneth Aldape, Javed Khan, Jing Wu
Publikováno v:
Cancers, Vol 13, Iss 23, p 6092 (2021)
Background: A consistent correlation between tumor mutation burden (TMB) and tumor immune microenvironment has not been observed in gliomas as in other cancers. Methods: Driver germline and somatic mutations, TMB, neoantigen, and immune cell signatur
Externí odkaz:
https://doaj.org/article/70515b633a5848d3903c0451d07be498
Autor:
Alice Ranjan, Ying Pang, Madison Butler, Mythili Merchant, Olga Kim, Guangyang Yu, Yu-Ting Su, Mark R. Gilbert, David Levens, Jing Wu
Publikováno v:
Cancers, Vol 13, Iss 12, p 3039 (2021)
Glioblastoma is the most common and aggressive primary malignant brain tumor, and more than two-thirds of patients with glioblastoma die within two years of diagnosis. The challenges of treating this disease mainly include genetic and microenvironmen
Externí odkaz:
https://doaj.org/article/296b3a1e9a1741f79db503dfeba12814
Autor:
Rosandra N. Kaplan, Olga Kim, Alice Ranjan, Martha Quezado, Jing Wu, Mythili Merchant, Liqiang Xi, Guangyang Yu, Megan Mackey, Kevin Camphausen, Matthias Holdhoff, Young K. Song, Zied Abdullaev, Kenneth Aldape, Kareem A. Zaghloul, David O. Kamson, Jun Wei, Terri S. Armstrong, Javed Khan, Sivasish Sindiri, Xinyu Wen, Ying Pang, Mark R. Gilbert, Svetlana Pack, Lisa Boris, Madison Butler, Ramya Antony, Orwa Aboud, Hsien-Chao Chou
Publikováno v:
JCO Precis Oncol
Autor:
Olga Kim, Madison Butler, Robert Robey, Raj Chari, Zach Sergi, Meili Zhang, Ying Pang, Guangyang Yu, Wei Zhang, Hua Song, Dionne Davis, Herui Wang, Mythili Merchant, Alice Ranjan, Mark Gilbert, Michael Gottesman, Yves Pommier, Jing Wu
Publikováno v:
Neuro-Oncology. 24:vii223-vii224
BACKGROUND Glioblastoma (GBM) is the most aggressive and lethal type of brain tumor. Activation of PI3K/mTOR pathway along with the loss of its primary negative regulator, phosphatase and tensin homolog (PTEN), occurs in nearly 50% of GBM patients. A
Autor:
Ying Pang, Guangyang Yu, Alice Ranjan, Herui Wang, Zach Sergi, Olga Kim, Mythili Merchant, Meili Zhang, Hua Song, Wei Zhang, Dionne Davis, Mark Gilbert, Zhenggang Liu, Jing Wu
Publikováno v:
Neuro-Oncology. 24:vii102-vii103
BACKGROUND IDH mutations are common in diffuse gliomas and confer an increased dependency on oxidative mitochondrial function. Zotiraciclib, a multi-kinase inhibitor, not only suppresses CDK9-mediated gene transcription process but also causes mitoch
Autor:
Alice Ranjan, Madison Butler, Olga Kim, Mythili Merchant, Jing Wu, Mark R. Gilbert, Guangyang Yu, Ying Pang, Yves Pommier
Publikováno v:
Neuro Oncol
BACKGROUND Glioblastoma is an aggressive brain tumor with high mortality. The development of new therapies is critical for improving patient outcomes. LMP400, a novel topoisomerase I (TOP1) inhibitor, traps TOP1 cleavage complexes, thereby generating
Autor:
Jing Wu, Ying Pang, Mark R. Gilbert, Yu-Ting Su, David Levens, Mythili Merchant, Madison Butler, Guangyang Yu, Alice Ranjan, Olga Kim
Publikováno v:
Cancers, Vol 13, Iss 3039, p 3039 (2021)
Cancers
Cancers
Simple Summary Inhibition of cyclin-dependent kinase 9 (CDK9) can impact multiple survival pathways in cancers and may be a promising therapeutic approach for glioblastoma, which is known to be highly resistant to treatments and thus challenging to t